Arraymap: A reference resource for genomic copy number imbalances in human malignancies

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Cai, Haoyang ^a   Kumar, Nitin ^a   Baudis, Michael ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARRAYMAP; ARTICLE; BIOINFORMATICS; COPY NUMBER VARIATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC PROCEDURES; GENETIC SELECTION; GLIOBLASTOMA; GLIOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE; REFERENCE DATABASE;

DATABASES, GENETIC; GENE DOSAGE; GENOME; GENOMICS; HUMANS; NEOPLASMS;

EID: 84862099805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036944     Document Type: Article

References (48)

1. Stallings RL, (2007) Are chromosomal imbalances important in cancer? Trends in genetics: TIG 23: 278-283.
2. Myllykangas S, Himberg J, Böhling T, Nagy B, Hollmén J, et al. (2006) DNA copy number amplification profiling of human neoplasms. Oncogene 25: 7324-7332.
3. Weir BA, Woo MS, Getz G, Perner S, Ding L, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
4. Wiedemeyer R, Brennan C, Heffernan TP, Xiao Y, Mahoney J, et al. (2008) Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer cell 13: 355-364.
5. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
6. Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
7. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
8. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and geneexpression subtypes of breast cancer. Genes, chromosomes & cancer 45: 1033-1040.
9. Hu X, Stern HM, Ge L, O'Brien C, Haydu L, et al. (2009) Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Molecular cancer research: MCR 7: 511-522.
10. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (New York, NY) 258: 818-821.
11. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature genetics 23: 41-46.
12. Bignell GR, Huang J, Greshock J, Watt S, Butler A, et al. (2004) High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome research 14: 287-295.
13. Baudis M, (2007) Genomic imbalances in 5918 malignant epithelial tumors: an explorative metaanalysis of chromosomal CGH data. BMC cancer 7: 226.
14. Alloza E, Al-Shahrour F, Cigudosa JC, Dopazo J, (2011) A large scale survey reveals that chromosomal copy-number alterations significantly affect gene modules involved in cancer initiation and progression. BMC medical genomics 4: 37.
15. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, et al. (2011) NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic acids research 39: D1005-10.
16. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, et al. (2010) ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic acids research 39: D1002-D1004.
17. Scheinin I, Myllykangas S, Borze I, Böhling T, Knuutila S, et al. (2008) CanGEM: mining gene copy number changes in cancer. Nucleic acids research 36: D830-5.
18. Cao Q, Zhou M, Wang X, Meyer CA, Zhang Y, et al. (2011) CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data. Nucleic acids research 39: D968-74.
19. Baudis M, Cleary ML, (2001) Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics (Oxford, England) 17: 1228-1229.
20. Baumbusch LO, Aarøe J, Johansen FE, Hicks J, Sun H, et al. (2008) Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC genomics 9: 379.
21. Curtis C, Lynch AG, Dunning MJ, Spiteri I, Marioni JC, et al. (2009) The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC genomics 10: 588.
22. Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, et al. (2007) A comparison of DNA copy number profiling platforms. Cancer research 67: 10173-10180.
23. Bengtsson H, Ray A, Spellman P, Speed TP, (2009) A single-sample method for normalizing and combining full-resolution copy numbers from multiple platforms, labs and analysis methods. Bioinformatics (Oxford, England) 25: 861-867.
24. Heinrichs S, Look T, (2007) Identification of structural aberrations in cancer by SNP array analysis. Genome biology pp. 1-5.
25. Carter NP, (2007) Methods and strategies for analyzing copy number variation using DNA microarrays. Nature genetics 39: S16-S21.
26. Lubin M, Lubin A, (2009) Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy. PloS one 4: e5735.
27. Krasinskas AM, Bartlett DL, Cieply K, Dacic S, (2010) CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 23: 531-538.
28. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, et al. (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Journal of the National Cancer Institute 93: 1246-1256.
29. Li J, (1997) PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer. Science (New York, NY) 275: 1943-1947.
30. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, et al. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proceedings of the National Academy of Sciences of the United States of America 103: 17402-17407.
31. Zhang W, Zhu J, Bai J, Jiang H, Liu F, et al. (2010) Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549. Journal of experimental & clinical cancer research: CR 29: 74.
32. van der Rhee JI, Krijnen P, Gruis NA, de Snoo FA, Vasen HFA, et al. (2011) Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A. Journal of the American Academy of Dermatology.
33. Bourdeaut F, Isidor B, Ferrand S, Thomas C, Moreau A, et al. (2011) Homozygous PTEN deletion in neuroblastoma arising in a child with Cowden syndrome. American journal of medical genetics Part A 155: 1763-1766.
34. Jin K, Kong X, Shah T, Penet MF, Wildes F, et al. (2011) Breast Cancer Special Feature: The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proceedings of the National Academy of Sciences of the United States of America.
35. Wiltshire RN, Rasheed BK, Friedman HS, Friedman AH, Bigner SH, (2000) Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neurooncology 2: 164-173.
36. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic acids research 39: D876-82.
37. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research 39: D945-50.
38. Gearhart J, Pashos EE, Prasad MK, (2007) Pluripotency redux-advances in stem-cell research. The New England journal of medicine 357: 1469-1472.
39. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, et al. (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America Vol. 79: 7824-7827.
40. Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, et al. (2007) Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer. Cancer research 67: 818-826.
41. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer cell 10: 529-541.
42. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, et al. (2012) 19p13.1 is a triple negative-specific breast cancer susceptibility locus. Cancer research.
43. Park NI, Rogan PK, Tarnowski HE, Knoll JHM, (2012) Structural and genic characterization of stable genomic regions in breast cancer: Relevance to chemotherapy. Molecular oncology.
44. Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, et al. (2009) DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. The American Journal of Human Genetics 84: 524-533.
45. Bengtsson H, Simpson K, Bullard J, Hansen K, (2008) aroma.affymetrix: A genetic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Tech Report #745 Department of Statistics, University of California, Berkeley.
46. Bengtsson H, Wirapati P, Speed TP, (2009) A single-array preprocessing method for estimating fullresolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics (Oxford, England) 25: 2149-2156.
47. Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, et al. (2010) Quality control and quality assurance in genotypic data for genome-wide association studies. Genetic Epidemiology 34: 591-602.
48. F C, AL A, SA K, TP S, VL SM, (2005) NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation. 2005 Meeting of the Federation of Clinical Immunology Societies Boston, MA.